On November 1, 2017 Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for cancer, respiratory and other diseases, reported that members of the management team will present at the following upcoming investor conferences (Press release, Pieris Pharmaceuticals, NOV 1, 2017, View Source [SID1234521395]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Stifel Healthcare Conference, Tuesday, November 14, 10:15 am EST at Lotte New York Palace Hotel, New York City. A webcast of the Company’s presentation will be available at this link.
Jefferies London Healthcare Conference, Thursday, November 16, 8:40 am GMT at the Waldorf Hilton, Aldwych, London.
Evercore ISI Biopharma Catalyst / Deep Dive Conference, Wednesday, November 29, 1:15 pm EST at the Boston Harbor Hotel, Boston.